Hey guys, so last week Mylan agreed to settle with investors over being engaged in a years-long scheme to fix prices for generic drugs and misled the public about its involvement in anticompetitive conduct.
Between 2013 and 2018, Mylan allegedly colluded with rival pharmaceutical companies to inflate prices of commonly used generic drugs. While this was happening, the company publicly stated it was complying with antitrust regulations. But government investigations, media reports, and internal documents later linked Mylan to a broader price-fixing conspiracy across the industry.
After receiving subpoenas and facing mounting legal pressure, $MYL stock declined as more information came to light. Investors filed suit, and Mylan has now agreed to settle the claims without admitting wrongdoing.
The final terms (including the total amount) are still being finalized, but investors can already [submit claims](https://11th.com/cases/myl-investor-settlement) to receive some compensation for their losses.